These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35306247)

  • 1. The effect of using an interactive mobile application for the management of chemotherapy-induced nausea and vomiting in children: Randomized controlled study.
    Semerci R; Akgün Kostak M; Taşkın C
    Eur J Oncol Nurs; 2022 Jun; 58():102121. PubMed ID: 35306247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity and Reliability of the Turkish Version of the Adapted Rhodes Index of Nausea and Vomiting for Pediatrics by Child (ARINVc) and by Parent (ARINVp).
    Akçay Didişen N; Yavuz B; Yardimci F; Basbakkal DZ
    J Pediatr Oncol Nurs; 2018; 35(5):353-360. PubMed ID: 29649925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Children's coping strategies for chemotherapy-induced nausea and vomiting.
    Rodgers C; Norville R; Taylor O; Poon C; Hesselgrave J; Gregurich MA; Hockenberry M
    Oncol Nurs Forum; 2012 Mar; 39(2):202-9. PubMed ID: 22374494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nurse-led multidomain intervention to improve the management of chemotherapy-induced nausea and vomiting in patients with head and neck cancers: A randomized controlled trial.
    Cao J; Chen C; Wang Y; Liu M; Han X; Li H
    Eur J Oncol Nurs; 2024 Jun; 70():102615. PubMed ID: 38797114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study.
    Hilarius DL; Kloeg PH; van der Wall E; van den Heuvel JJ; Gundy CM; Aaronson NK
    Support Care Cancer; 2012 Jan; 20(1):107-17. PubMed ID: 21258948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, safety and feasibility of fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in pediatric patients receiving moderately and highly emetogenic chemotherapy - results of a non-interventional observation study.
    Willier S; Cabanillas Stanchi KM; von Have M; Binder V; Blaeschke F; Feucht J; Feuchtinger T; Döring M
    BMC Cancer; 2019 Nov; 19(1):1118. PubMed ID: 31730451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of chemotherapy-induced nausea and vomiting.
    Dewan P; Singhal S; Harit D
    Indian Pediatr; 2010 Feb; 47(2):149-55. PubMed ID: 20228428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nausea and vomiting perspectives among children receiving moderate to highly emetogenic chemotherapy treatment.
    Rodgers C; Kollar D; Taylor O; Bryant R; Crockett K; Gregurich MA; Hockenberry M
    Cancer Nurs; 2012; 35(3):203-10. PubMed ID: 21915041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan.
    Tamura K; Aiba K; Saeki T; Nakanishi Y; Kamura T; Baba H; Yoshida K; Yamamoto N; Kitagawa Y; Maehara Y; Shimokawa M; Hirata K; Kitajima M;
    Int J Clin Oncol; 2015 Oct; 20(5):855-65. PubMed ID: 25681876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy-induced nausea and vomiting is less controlled at delayed phase in patients with esophageal cancer: a prospective registration study by the CINV Study Group of Japan.
    Baba Y; Baba H; Yamamoto S; Shimada H; Shibata T; Miyazaki T; Yoshikawa T; Nakajima Y; Tsuji Y; Shimokawa M; Kitagawa Y; Aiba K
    Dis Esophagus; 2017 Feb; 30(2):1-7. PubMed ID: 27001532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis.
    Natale JJ
    Hosp Pract (1995); 2015; 43(4):226-34. PubMed ID: 26308912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy-induced nausea and vomiting: incidence and characteristics of persistent symptoms and future directions NCCTG N08C3 (Alliance).
    Kottschade L; Novotny P; Lyss A; Mazurczak M; Loprinzi C; Barton D
    Support Care Cancer; 2016 Jun; 24(6):2661-7. PubMed ID: 26768436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact and management of chemotherapy/radiotherapy-induced nausea and vomiting and the perceptual gap between oncologists/oncology nurses and patients: a cross-sectional multinational survey.
    Vidall C; Fernández-Ortega P; Cortinovis D; Jahn P; Amlani B; Scotté F
    Support Care Cancer; 2015 Nov; 23(11):3297-305. PubMed ID: 25953380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of a clinical pharmacist-led service to optimize management of refractory chemotherapy-induced nausea and vomiting in adult hematology/oncology clinic.
    Quinn CS; Bergsbaken JJ; Blessinger EJ; Piccolo JK
    J Oncol Pharm Pract; 2022 Oct; 28(7):1499-1507. PubMed ID: 34225524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of text message reminders on nausea, vomiting and quality of life in children with cancer receiving cisplatin.
    Akdeniz Kudubes A; Bektas M; İnce D; Olgun N
    J Pediatr Nurs; 2022; 64():e109-e118. PubMed ID: 34955361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of chemotherapy-induced nausea and vomiting in Taiwan: physicians' and nurses' estimation vs. patients' reported outcomes.
    Liau CT; Chu NM; Liu HE; Deuson R; Lien J; Chen JS
    Support Care Cancer; 2005 May; 13(5):277-86. PubMed ID: 15770489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metoclopramide, Dexamethasone, or Palonosetron for Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting After Moderately Emetogenic Chemotherapy (MEDEA): A Randomized, Phase III, Noninferiority Trial.
    van der Vorst MJDL; Toffoli EC; Beusink M; van Linde ME; van Voorthuizen T; Brouwer S; van Zweeden AA; Vrijaldenhoven S; Berends JC; Berkhof J; Verheul HMW
    Oncologist; 2021 Jan; 26(1):e173-e181. PubMed ID: 32735029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy-induced nausea and vomiting (CINV) in 190 colorectal cancer patients: a prospective registration study by the CINV study group of Japan.
    Tsuji Y; Baba H; Takeda K; Kobayashi M; Oki E; Gotoh M; Yoshida K; Shimokawa M; Kakeji Y; Aiba K
    Expert Opin Pharmacother; 2017 Jun; 18(8):753-758. PubMed ID: 28395603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric oncology provider perspectives and patient/family perceptions of chemotherapy-induced nausea and vomiting management: Experiences at an academic medical center.
    Bloomhardt H; Rubin M; Xue Y; Jin Z; Masino L; Seidel D; Hijiya N; Beauchemin M
    Pediatr Blood Cancer; 2024 Apr; 71(4):e30883. PubMed ID: 38279826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor chemotherapy-induced nausea and vomiting control in children receiving intermediate or high dose methotrexate.
    Vol H; Flank J; Lavoratore SR; Nathan PC; Taylor T; Zelunka E; Maloney AM; Lee Dupuis L
    Support Care Cancer; 2016 Mar; 24(3):1365-71. PubMed ID: 26335406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.